Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by American Century Companies Inc.

American Century Companies Inc. lowered its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 1.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,134,284 shares of the company’s stock after selling 12,263 shares during the quarter. American Century Companies Inc. owned 0.43% of Ryan Specialty worth $72,776,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Sanctuary Advisors LLC boosted its position in shares of Ryan Specialty by 1.2% during the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company’s stock worth $1,045,000 after purchasing an additional 188 shares during the period. State of Alaska Department of Revenue lifted its stake in Ryan Specialty by 1.6% during the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock worth $778,000 after purchasing an additional 190 shares in the last quarter. CIBC Asset Management Inc grew its stake in shares of Ryan Specialty by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company’s stock valued at $236,000 after buying an additional 196 shares in the last quarter. Loomis Sayles & Co. L P raised its holdings in shares of Ryan Specialty by 26.3% in the 3rd quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock valued at $91,000 after buying an additional 286 shares during the period. Finally, Exchange Traded Concepts LLC lifted its stake in Ryan Specialty by 2.6% during the 4th quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company’s stock worth $755,000 after acquiring an additional 295 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

Insider Buying and Selling at Ryan Specialty

In other news, Director Nicholas Dominic Cortezi sold 29,466 shares of Ryan Specialty stock in a transaction on Monday, January 13th. The shares were sold at an average price of $65.06, for a total value of $1,917,057.96. Following the transaction, the director now directly owns 45,409 shares of the company’s stock, valued at $2,954,309.54. The trade was a 39.35 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The disclosure for this sale can be found here. Insiders sold 241,360 shares of company stock worth $16,006,428 over the last 90 days. Corporate insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have issued reports on RYAN shares. Morgan Stanley started coverage on shares of Ryan Specialty in a research note on Thursday, December 5th. They set an “overweight” rating and a $90.00 price target on the stock. UBS Group increased their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a report on Wednesday, February 26th. Wells Fargo & Company boosted their price target on shares of Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a research note on Friday, February 21st. Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a research note on Friday, February 21st. Finally, Royal Bank of Canada lowered their target price on Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research note on Friday, February 21st. One research analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $75.27.

Ryan Specialty Trading Up 0.1 %

RYAN opened at $72.43 on Wednesday. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a one year low of $48.48 and a one year high of $75.97. The company has a market cap of $18.97 billion, a P/E ratio of 104.97, a PEG ratio of 1.19 and a beta of 0.71. The business’s 50-day simple moving average is $68.39 and its 200-day simple moving average is $68.13.

Ryan Specialty (NYSE:RYAN) last announced its quarterly earnings results on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.02). The company had revenue of $663.53 million during the quarter, compared to analysts’ expectations of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. As a group, equities research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were given a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, March 4th. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a yield of 0.66%. Ryan Specialty’s payout ratio is 69.57%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.